CMBA
JAZZ icon

C.M. Bidwell & Associates’s Jazz Pharmaceuticals JAZZ Stock Holding History

C.M. Bidwell & Associates’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-644
Closed -$80K – 474
2025
Q1 		$80K Sell
644
-15
-2% -$1.96K 0.05% 175
2024
Q4 		$81.2K Sell
659
-3
-0.5% -$354 0.05% 187
2024
Q3 		$73.8K Buy
+662
New +$72.5K 0.05% 202
2023
Q4 		– Sell
-1,093
Closed -$141K – 534
2023
Q3 		$141K Buy
+1,093
New +$146K 0.11% 163
2023
Q2 		– Sell
-689
Closed -$101K – 556
2023
Q1 		$101K Sell
689
-52
-7% -$7.69K 0.08% 231
2022
Q4 		$118K Buy
741
+451
+156% +$66.1K 0.09% 197
2022
Q3 		$39K Hold
290
– – 0.03% 290
2022
Q2 		$45K Hold
290
– – 0.04% 284
2022
Q1 		$45K Buy
+290
New +$42.1K 0.03% 293
2021
Q3 		– Sell
-1,615
Closed -$287K – 588
2021
Q2 		$287K Buy
1,615
+155
+11% +$26.8K 0.19% 95
2021
Q1 		$240K Sell
1,460
-200
-12% -$32.9K 0.18% 100
2020
Q4 		$274K Sell
1,660
-70
-4% -$10.4K 0.22% 67
2020
Q3 		$247K Buy
+1,730
New +$214K 0.23% 79
2019
Q2 		– Sell
-1,815
Closed -$259K – 423
2019
Q1 		$259K Buy
+1,815
New +$237K 0.26% 106
2014
Q2 		– Sell
-1,415
Closed -$196K – 264
2014
Q1 		$196K Sell
1,415
-365
-21% -$54.9K 0.05% 144
2013
Q4 		$225K Buy
+1,780
New +$184K 0.06% 149

Other funds holding JAZZ

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

C.M. Bidwell & Associates's JAZZ Position: Q2 2025 in Review

C.M. Bidwell & Associates sold out of Jazz Pharmaceuticals (JAZZ) in Q2 2025, closing a stake of 644 shares — an estimated $80K sold.

C.M. Bidwell & Associates first reported a position in JAZZ in Q4 2013 and held it in 16 quarters. The position peaked at $287K in Q2 2021. 502 funds tracked by Wall St. Rank hold JAZZ as of Q2 2025.

  • C.M. Bidwell & Associates reported no remaining Jazz Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • C.M. Bidwell & Associates sold 644 Jazz Pharmaceuticals shares in Q2 2025, an estimated $80K.
  • C.M. Bidwell & Associates first reported a position in Jazz Pharmaceuticals in Q4 2013 and held it in 16 quarters.
  • C.M. Bidwell & Associates's Jazz Pharmaceuticals position peaked at $287K in Q2 2021.
  • 502 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2025.

Based on C.M. Bidwell & Associates's 13F filing for Q2 2025, filed 14 Aug 2025.